Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
Boursier J, Roux M, Costentin C, Chaigneau J, Fournier-Poizat C, Trylesinski A, Canivet CM, Michalak S, Le Bail B, Paradis V, Bedossa P, Sturm N, de Ledinghen V; AFEF group for the study of liver fibrosis; M118 study group; Newsome PN. Boursier J, et al. Nat Commun. 2023 Aug 26;14(1):5219. doi: 10.1038/s41467-023-40328-4. Nat Commun. 2023. PMID: 37633932 Free PMC article.
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD.
Canivet CM, Costentin C, Irvine KM, Delamarre A, Lannes A, Sturm N, Oberti F, Patel PJ, Decaens T, Irles-Depé M, Fouchard I, Hermabessière P, Roux M, Barthelon J, Calès P, Powell EE, de Ledinghen V, Boursier J. Canivet CM, et al. Among authors: hermabessiere p. Hepatology. 2023 Mar 1;77(3):920-930. doi: 10.1002/hep.32665. Epub 2023 Feb 17. Hepatology. 2023. PMID: 35822302
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Pons M, Rivera-Esteban J, Ma MM, Davyduke T, Delamarre A, Hermabessière P, Dupuy J, Wong GL, Yip TC, Pennisi G, Tulone A, Cammà C, Petta S, de Lédinghen V, Wong VW, Augustin S, Pericàs JM, Abraldes JG, Genescà J. Pons M, et al. Among authors: hermabessiere p. Clin Gastroenterol Hepatol. 2023 Aug 11:S1542-3565(23)00626-2. doi: 10.1016/j.cgh.2023.08.004. Online ahead of print. Clin Gastroenterol Hepatol. 2023. PMID: 37573987
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications.
Boursier J, Canivet CM, Costentin C, Lannes A, Delamarre A, Sturm N, Le Bail B, Michalak S, Oberti F, Hilleret MN, Irles-Depé M, Fouchard I, Hermabessiere P, Barthelon J, Calès P, Cariou B, de Ledinghen V, Roux M. Boursier J, et al. Among authors: hermabessiere p. Clin Gastroenterol Hepatol. 2023 May;21(5):1243-1251.e12. doi: 10.1016/j.cgh.2022.02.059. Epub 2022 Mar 11. Clin Gastroenterol Hepatol. 2023. PMID: 35288342
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
Carrieri P, Bourlière M, Di Beo V, Lusivika-Nzinga C, Ramier C, Antwerpes S, Protopopescu C, Lacombe JM, Pol S, Fontaine H, Mourad A, Carrat F, Duracinsky M, Marcellin F; ANRS/AFEF HEPATHER Study Group. Carrieri P, et al. Qual Life Res. 2023 Dec;32(12):3427-3438. doi: 10.1007/s11136-023-03496-w. Epub 2023 Aug 16. Qual Life Res. 2023. PMID: 37587323